abstract |
The present invention relates to novel alkyl-substituted piperazine derivatives useful as monoamine neurotransmitter reuptake inhibitors. In another aspect, the invention relates to the use of these compounds in a method of treatment and to pharmaceutical compositions comprising the compounds of the invention. |